Healthcare+ Advocate General in C 456/24 Halozyme: The MA has the final say on what constitutes an “active ingredient”A substance expressly designated in the marketing authorisation as an excipient cannot be regarded as an active ingredient for SPC purposes, according to AG EmiliouRead More 23Apr2026 Innovation in FemTechIntroducing our new article series exploring emerging technologies and IPRead More 08Apr2026 Managing IP Rankings 202525 Carpmaels practitioners recommended in this year’s rankingsRead More 06Oct2025 Belgian Patent Court weighs in on the requirements and scope of the manufacturing waiverWe look into the manufacturing waiver and how the Belgian Courts applied itRead More 09Sep2025 UK SPC law – changes as of 1st January 2025The UK’s SPC system has adjusted to the UK’s new regulatory regime under the Windsor FrameworkRead More 01Sep2025 A checkpoint for antibody SPC applications in France?The French Supreme Court offers a new take on the interpretation of Article 3(a), as applied to an SPC application for an antibody that acts as an immune checkpoint inhibitorRead More 01Sep2025 No SPCs for new medical indications: Court of Appeal holds the “bright line”Merck Serono’s appeal dismissed by the Court of AppealRead More 29Aug2025 CJEU confirms guidance on Articles 3(a) and 3(c) in C-119/22 and C-149/22 MerckSPC applicants still facing uncertainty on Article 3(a)Read More 28Aug2025 Lexology Index: IP 202515 partners recognised in this year’s editionRead More 27Aug2025 Council adopts position on EU pharma packageMajor changes to the EU’s pharmaceutical regime, including to regulatory exclusivity periods, are now one step closer.Read More 03Jul202512345> Type Firm News Insights PodcastsServiceProtectDealDisputeSectorHealthcare+Energy+Life SciencesChemistryMaterialsEngineeringTechCreativeArchive2026MayAprilMarchFebruaryJanuary2025DecemberNovemberOctoberSeptemberAugustJulyJuneAprilMarchFebruaryJanuary2024DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2023DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2022DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2021DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2020DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2019DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2018DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2017DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2016DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2015DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2014DecemberNovemberOctoberAugustJulyJuneMayAprilMarchFebruaryJanuary2013DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchJanuary2012NovemberJulyJuneMayAprilFebruaryJanuary
